MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

GALWAY, Ireland, June 12, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the ...

Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.

Medtronic has announced that its diabetes business, which will operate under the name MiniMed, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) ...

After a long delay, the U.S. Food and Drug Administration has approved Medtronic's MiniMed 780G device, the company's next-generation insulin pump. Medtronic's diabetes division has been under a ...

Just a few months after Medtronic resolved a late 2021 FDA warning letter describing quality control issues at the headquarters of its diabetes division, that segment of its business is in the hot ...

Medtronic has secured a new approval in Europe, greatly expanding the reach of its MiniMed 780G pump system—including for people with Type 2 diabetes who require insulin. The CE mark also opens it up ...

Moving its aggressive acquisition campaign into the field of diabetes management, Medtronic Inc., the world’s biggest medical device maker, agreed to buy Northridge-based MiniMed Inc. and an ...

GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of ...

Medtronic's MiniMed Group filed for a U.S. initial public offering on Friday, as the medical device maker moves ahead with ...